Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Systane Complete
- Development stage
- Unknown
- Lead developer
- Alcon
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
FID 114657 is the development code for **Systane Complete**, a multi-action lubricant eye drop developed by Alcon for the treatment of dry eye disease. The formulation is a nanoemulsion designed to replenish and stabilize all three layers of the tear film: the mucin, aqueous, and lipid layers. It contains **propylene glycol** as a demulcent to provide immediate lubrication and **hydroxypropyl guar (HP-Guar)**, which forms a protective mucomimetic matrix on the ocular surface to promote healing and long-lasting relief. Additionally, the formulation incorporates a lipid component, **dimyristoyl phosphatidylglycerol (DMPG)**, in a nanoemulsion format to supplement the tear lipid layer and reduce evaporation. Clinical studies have demonstrated its efficacy in increasing tear lipid layer thickness and improving tear film break-up time (TFBUT) in patients with dry eye and contact lens wearers.
- Brand names
- Systane Complete
- Other names
- FID 114657FID114657FID-114657Alcon FID 114657Lubricant Eye Drops
Beyond the preview
Go deeper on Systane Complete.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Systane Complete.